德适生物(DIAGENS-B)宣布,已与浙江安贞儿医疗AI技术公司正式签署合作框架协议。这一举措标志着双方将在医疗人工智能领域展开深度合作,共同探索技术创新与应用落地的新路径。
德适生物(DIAGENS-B)宣布,已与浙江安贞儿医疗AI技术公司正式签署合作框架协议。这一举措标志着双方将在医疗人工智能领域展开深度合作,共同探索技术创新与应用落地的新路径。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.